Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sonic Healthcare Limited ( (AU:SHL) ) has provided an update.
Sonic Healthcare Limited announced a change in the director’s interest notice, specifically concerning Christopher David Wilks. The notice details changes in the number of ordinary shares and unlisted options held directly and indirectly by the director, reflecting adjustments in the company’s stock and options management. This update is significant for stakeholders as it highlights the company’s ongoing commitment to transparency in its corporate governance practices.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.50 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, providing medical diagnostic services. The company focuses on delivering laboratory and radiology services to medical practitioners, hospitals, and their patients.
Average Trading Volume: 1,683,183
Technical Sentiment Signal: Sell
Current Market Cap: A$11.41B
For a thorough assessment of SHL stock, go to TipRanks’ Stock Analysis page.